动物用药品市场分析及预测（至2035年）：依类型、产品、服务、技术、应用、形式、最终用户及设备划分

预计动物用药品市场规模将从2024年的456亿美元成长到2034年的782亿美元，年复合成长率约为5.2%。动物用药品市场涵盖专门用于动物健康的药品、疫苗和医疗设备。该行业致力于伴侣动物和牲畜的护理，并专注于疾病预防、治疗和健康促进。市场的主要驱动因素包括宠物主人数量的增加、兽医治疗方法的进步以及畜牧业产量的成长。生物製药和个人化医疗的创新，以及监管政策的发展，对于推动市场成长和机会至关重要。

动物用药品市场正经历强劲成长，这主要得益于动物保健技术的进步和宠物饲养率的上升。其中，药品细分市场成长率最高，主要得益于抗寄生虫药和抗感染药在疾病预防和治疗中的重要作用。疫苗细分市场紧随其后，其成长动力来自意识提升以及对抗通用感染疾病的需求。诊断细分市场成长率位居第二，其中临床生物化学检验和免疫诊断展现出巨大的潜力。这些细分市场对于疾病的早期发现和管理至关重要，有助于改善动物健康。伴侣动物诊断细分市场尤其受到关注，反映出人们对宠物健康管理的日益重视。就地检验和数位成像诊断等技术创新进一步推动了市场成长。远端医疗和移动兽医服务的兴起也为满足宠物饲主和动物饲养管理者不断变化的需求提供了盈利的机会。该行业对永续发展和精准医疗的关注将继续塑造其未来的发展轨迹。

由于定价策略的多样化和创新产品推出，动物用药品市场正经历市场份额的动态变化。主要企业正致力于透过推出先进的药品和生物製药来拓展产品系列。这一趋势的驱动力在于不断增长的动物保健需求以及人们对通用感染疾病意识提升。各公司也正在采用具竞争力的定价模式来拓展更广大的消费群。这种环境为新参与企业和现有企业都创造了有利的市场条件，有望带来强劲的成长和创新。动物用药品市场的竞争异常激烈，主要企业相互参照，以维持和巩固其市场地位。监管的影响至关重要，严格的指导方针影响产品开发和核准流程。北美和欧洲凭藉其成熟的兽医实践和法规结构，仍然是重要的市场。同时，受宠物饲养和畜牧业发展推动，亚太新兴市场正经历快速成长。在这种竞争激烈且严格监管的环境下，策略灵活性和合规性对于抓住快速成长机会至关重要。

主要趋势和驱动因素：

受宠物主人数量不断增长和动物健康意识提升日益增强的推动，动物用药品市场正经历强劲增长。随着宠物饲主更积极主动管理宠物健康，预防性照护（包括定期体检和疫苗接种）的普及率不断提高。这种转变推动了对兽医服务和药品的需求，刺激了市场扩张。科技创新正在改变这个产业，远端医疗和穿戴式动物健康监测设备等新技术正日益普及。这些技术提供便利和即时健康讯息，吸引了精通技术的消费者，并提高了兽医护理的品质。此外，人们对伴侣动物健康的日益关注促使研发投入增加，新产品不断推出，治疗方法方案也更加多样化。同时，由于全球肉类消费量的增长和对高效疾病管理的需求，畜牧业也经历了显着增长。这种需求推动了兽药治疗和诊断市场的发展。新兴市场蕴藏着众多机会，这些市场中可支配收入的增加和都市化的加速正在推动宠物饲养和畜牧业的发展。能够提供创新、经济高效的解决方案的公司，将更有利于利用这些趋势，并推动未来的市场成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

• 宏观经济分析
• 市场趋势
• 市场驱动因素
• 市场机会
• 市场限制
• 复合年均成长率：成长分析
• 影响分析
• 新兴市场
• 技术蓝图
• 战略框架

第四章 细分市场分析

• 市场规模及预测：依类型
  • 製药
  • 生物製药
  • 药用饲料添加剂
• 市场规模及预测：依产品划分
  • 疫苗
  • 驱虫药
  • 抗感染剂
  • 药用饲料添加剂
  • 诊断产品
• 市场规模及预测：依服务划分
  • 兽医医院和诊所
  • 检查服务
  • 远端医疗
• 市场规模及预测：依技术划分
  • 基因组检测
  • 生物技术
  • 奈米科技
• 市场规模及预测：依应用领域划分
  • 伴侣动物
  • 家畜
  • 水生动物
• 市场规模及预测：依类型
  • 药片
  • 注射
  • 粉末
  • 液体
• 市场规模及预测：依最终用户划分
  • 动物诊所
  • 兽医诊所
  • 研究所
• 市场规模及预测：依设施划分
  • 手术器械
  • 诊断设备
  • 监控设备
  • 治疗设备

第五章 区域分析

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲
• 亚太地区
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲
  • 台湾
  • 亚太其他地区
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 其他欧洲
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非
  • 撒哈拉以南非洲
  • 其他中东和非洲地区

第六章 市场策略

• 需求与供给差距分析
• 贸易和物流限制
• 价格、成本和利润率趋势
• 市场渗透率
• 消费者分析
• 法规概述

第七章 竞争讯息

• 市场定位
• 市场占有率
• 竞争基准
• 主要企业的策略

第八章：公司简介

• Virbac
• Vetoquinol
• Dechra Pharmaceuticals
• Boehringer Ingelheim Animal Health
• Zoetis
• Elanco Animal Health
• Merck Animal Health
• Ceva Sante Animale
• Bayer Animal Health
• Merial
• Norbrook
• Phibro Animal Health
• Huvepharma
• KRKA Animal Health
• Hipra
• Biogenesis Bago
• Kyoritsu Seiyaku
• Neogen Corporation
• IDEXX Laboratories
• Ourofino Saude Animal

第九章：关于我们

Veterinary Medicine Market is anticipated to expand from $45.6 billion in 2024 to $78.2 billion by 2034, growing at a CAGR of approximately 5.2%. The Veterinary Medicine Market encompasses pharmaceuticals, vaccines, and medical devices tailored for animal health. This sector addresses companion and livestock animal care, focusing on disease prevention, treatment, and wellness. Key drivers include rising pet ownership, advancements in veterinary therapeutics, and increasing livestock production. Innovation in biologics and personalized medicine is pivotal, alongside regulatory advancements, enhancing market growth and opportunities.

The Veterinary Medicine Market is experiencing robust growth, propelled by advancements in animal healthcare and rising pet ownership. The pharmaceuticals segment is the top performer, with parasiticides and anti-infectives leading due to their critical role in disease prevention and treatment. The vaccines sub-segment follows closely, driven by increasing awareness of preventive healthcare and the need to combat zoonotic diseases. The diagnostics segment is the second highest performing, with clinical biochemistry and immunodiagnostics showing significant promise. These sub-segments are essential for early disease detection and management, enhancing animal health outcomes. Companion animal diagnostics are particularly gaining traction, reflecting the growing emphasis on pet wellness. Technological innovations, such as point-of-care testing and digital imaging, are further propelling market growth. The rise of telemedicine and mobile veterinary services also presents lucrative opportunities, catering to the evolving needs of pet owners and livestock managers. The industry's focus on sustainable practices and precision medicine continues to shape its future trajectory.

The Veterinary Medicine Market is experiencing a dynamic shift in market share, with diverse pricing strategies and innovative product launches. Key players are focusing on expanding their portfolios by introducing advanced pharmaceuticals and biologics. This trend is driven by the rising demand for animal healthcare and the increasing awareness of zoonotic diseases. Companies are also adopting competitive pricing models to capture a larger consumer base. This environment fosters a rich landscape for new entrants and established firms alike, promising robust growth and innovation. Competition within the Veterinary Medicine Market is intense, with leading firms benchmarking against each other to maintain and enhance their market positions. Regulatory influences play a crucial role, with stringent guidelines affecting product development and approval processes. North America and Europe remain significant markets due to established veterinary practices and regulatory frameworks. Meanwhile, emerging markets in Asia-Pacific are witnessing rapid growth, fueled by increasing pet ownership and livestock farming. This competitive and regulatory landscape necessitates strategic agility and compliance to capitalize on burgeoning opportunities.

Geographical Overview:

The veterinary medicine market is witnessing notable growth, with regional dynamics playing a crucial role. North America remains at the forefront, driven by advanced healthcare infrastructure and increasing pet ownership. The region's emphasis on innovation and research significantly contributes to its market leadership. Europe follows, with robust veterinary healthcare policies and a strong focus on animal welfare fueling market expansion. Asia Pacific is emerging as a promising growth pocket. Rising disposable incomes and pet adoption rates are key drivers in this region. Countries like China and India are experiencing rapid market growth, bolstered by increased awareness of animal health. Latin America is also gaining traction, with Brazil and Mexico leading the charge due to rising investments in veterinary services. The Middle East & Africa, though in nascent stages, show potential. Growing government initiatives and awareness campaigns are paving the way for future market opportunities in these regions.

Global tariffs and geopolitical tensions are intricately influencing the Veterinary Medicine Market, particularly in Japan, South Korea, China, and Taiwan. These nations are recalibrating strategies to mitigate tariff impacts, with Japan and South Korea focusing on enhancing local production capabilities. China is advancing its domestic veterinary pharmaceutical sector to reduce reliance on imports. Taiwan remains a vital player due to its advanced biotech capabilities but faces geopolitical vulnerabilities. The global veterinary medicine market is witnessing robust growth, driven by rising pet ownership and livestock health investments. By 2035, the market is projected to expand significantly, contingent upon resilient supply chains and strategic regional partnerships. Meanwhile, Middle East conflicts are exacerbating energy price volatility, indirectly affecting production costs and supply chain stability.

Key Trends and Drivers:

The veterinary medicine market is experiencing robust growth propelled by increased pet ownership and heightened awareness of animal health. There is a rising trend in the adoption of preventive care, which includes regular check-ups and vaccinations, as pet owners become more proactive in managing their pets' health. This shift is driving demand for veterinary services and pharmaceuticals, fostering market expansion. Technological advancements are revolutionizing the industry, with innovations such as telemedicine and wearable health monitoring devices for animals gaining traction. These technologies offer convenience and real-time health insights, appealing to tech-savvy consumers and enhancing veterinary care. Additionally, the growing focus on companion animal health is leading to increased investments in research and development, driving new product launches and treatment options. Furthermore, the livestock sector is witnessing significant growth due to rising global meat consumption and the need for efficient disease management. This demand is bolstering the market for veterinary therapeutics and diagnostics. Opportunities abound in emerging markets, where rising disposable incomes and urbanization are increasing pet ownership and livestock farming. Companies that can offer innovative, cost-effective solutions are well-positioned to capitalize on these trends and drive future market growth.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Form
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Equipment

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Pharmaceuticals
  • 4.1.2 Biologicals
  • 4.1.3 Medicated Feed Additives
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Vaccines
  • 4.2.2 Parasiticides
  • 4.2.3 Anti-Infectives
  • 4.2.4 Medicinal Feed Additives
  • 4.2.5 Diagnostic Products
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Veterinary Hospitals and Clinics
  • 4.3.2 Laboratory Testing Services
  • 4.3.3 Telemedicine
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Genomic Testing
  • 4.4.2 Biotechnology
  • 4.4.3 Nanotechnology
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Companion Animals
  • 4.5.2 Livestock Animals
  • 4.5.3 Aquatic Animals
• 4.6 Market Size & Forecast by Form (2020-2035)
  • 4.6.1 Tablets
  • 4.6.2 Injectables
  • 4.6.3 Powders
  • 4.6.4 Liquids
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Veterinary Clinics
  • 4.7.2 Veterinary Hospitals
  • 4.7.3 Research Institutes
• 4.8 Market Size & Forecast by Equipment (2020-2035)
  • 4.8.1 Surgical Equipment
  • 4.8.2 Diagnostic Equipment
  • 4.8.3 Monitoring Equipment
  • 4.8.4 Therapeutic Equipment

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 Form
    • 5.2.1.7 End User
    • 5.2.1.8 Equipment
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 Form
    • 5.2.2.7 End User
    • 5.2.2.8 Equipment
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 Form
    • 5.2.3.7 End User
    • 5.2.3.8 Equipment
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 Form
    • 5.3.1.7 End User
    • 5.3.1.8 Equipment
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 Form
    • 5.3.2.7 End User
    • 5.3.2.8 Equipment
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 Form
    • 5.3.3.7 End User
    • 5.3.3.8 Equipment
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 Form
    • 5.4.1.7 End User
    • 5.4.1.8 Equipment
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 Form
    • 5.4.2.7 End User
    • 5.4.2.8 Equipment
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 Form
    • 5.4.3.7 End User
    • 5.4.3.8 Equipment
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 Form
    • 5.4.4.7 End User
    • 5.4.4.8 Equipment
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 Form
    • 5.4.5.7 End User
    • 5.4.5.8 Equipment
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 Form
    • 5.4.6.7 End User
    • 5.4.6.8 Equipment
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 Form
    • 5.4.7.7 End User
    • 5.4.7.8 Equipment
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 Form
    • 5.5.1.7 End User
    • 5.5.1.8 Equipment
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 Form
    • 5.5.2.7 End User
    • 5.5.2.8 Equipment
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 Form
    • 5.5.3.7 End User
    • 5.5.3.8 Equipment
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 Form
    • 5.5.4.7 End User
    • 5.5.4.8 Equipment
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 Form
    • 5.5.5.7 End User
    • 5.5.5.8 Equipment
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 Form
    • 5.5.6.7 End User
    • 5.5.6.8 Equipment
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 Form
    • 5.6.1.7 End User
    • 5.6.1.8 Equipment
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 Form
    • 5.6.2.7 End User
    • 5.6.2.8 Equipment
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 Form
    • 5.6.3.7 End User
    • 5.6.3.8 Equipment
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 Form
    • 5.6.4.7 End User
    • 5.6.4.8 Equipment
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 Form
    • 5.6.5.7 End User
    • 5.6.5.8 Equipment

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Virbac
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Vetoquinol
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Dechra Pharmaceuticals
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Boehringer Ingelheim Animal Health
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Zoetis
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Elanco Animal Health
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Merck Animal Health
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Ceva Sante Animale
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Bayer Animal Health
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Merial
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Norbrook
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Phibro Animal Health
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Huvepharma
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 KRKA Animal Health
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Hipra
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Biogenesis Bago
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Kyoritsu Seiyaku
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Neogen Corporation
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 IDEXX Laboratories
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Ourofino Saude Animal
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us